Socfinasia
ISIN
LU0092047413
Ticker
SCFNS
Sector
Sub-Industry
Country
Luxembourg
Year Founded
1972
ISIN
LU0092047413
Ticker
SCFNS
Sector
Sub-Industry
Country
Luxembourg
Year Founded
1972
Socfin, Socfinaf and Socfinasia are three Luxembourg companies listed on the Luxembourg Stock Exchange.
Their activities consist of managing a portfolio of holdings focused on the development of more than 191 900 hectares of tropical oil palm and rubber plantations located in Africa and South-East Asia.
Worldwide
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 | 01.01.2024 |
|---|---|---|---|---|---|
| Assets | N/A | 336,155,793.00 | 486,823,921.00 | 418,554,755.00 | 363,377,734.00 |
| Noncurrent Assets | N/A | 261,423,989.00 | 371,730,899.00 | 273,134,665.00 | 217,572,944.00 |
| Property Plant And Equipment | N/A | 40,157,598.00 | 41,308,451.00 | 40,992,845.00 | 39,209,888.00 |
| Intangible Assets Other Than Goodwill | N/A | 208,262.00 | 828,613.00 | 237,776.00 | 301,923.00 |
| Investments In Associates Accounted For Using Equity Method | N/A | 20,600,069.00 | 21,934,906.00 | 25,588,659.00 | 22,687,671.00 |
| Noncurrent Biological Assets | N/A | 107,369,830.00 | 115,405,596.00 | 90,355,051.00 | 91,842,656.00 |
| Deferred Tax Assets | N/A | 3,557,425.00 | 7,870,916.00 | 5,817,338.00 | 5,105,504.00 |
| Noncurrent Loans And Receivables | N/A | 80,387,666.00 | 175,971,270.00 | 100,503,325.00 | N/A |
| Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income | N/A | 584,990.00 | 501,082.00 | 773,528.00 | 5,231,277.00 |
| Other Noncurrent Assets | N/A | 7,600,000.00 | 7,000,000.00 | 7,000,000.00 | 0.00 |
| Current Assets | N/A | 74,731,804.00 | 115,093,022.00 | 145,420,090.00 | 145,804,790.00 |
| Inventories | N/A | 11,766,833.00 | 16,115,866.00 | 15,945,854.00 | 16,916,698.00 |
| Current Trade Receivables | N/A | 1,994,383.00 | 2,304,055.00 | 3,141,096.00 | 2,259,161.00 |
| Other Current Receivables | N/A | 40,157,782.00 | 20,904,231.00 | 28,426,558.00 | 9,924,598.00 |
| Current Tax Assets Current | N/A | 980,690.00 | 1,228,967.00 | 1,574,532.00 | 743,616.00 |
| Current Biological Assets | N/A | 0.00 | 1,135,194.00 | 1,684,003.00 | 1,386,059.00 |
| Cash and cash equivalents | 12,592,654.00 | 19,832,116.00 | 73,404,709.00 | 94,648,047.00 | 114,574,658.00 |
| Equity And Liabilities | N/A | 336,155,793.00 | 486,823,921.00 | 418,554,755.00 | 363,377,734.00 |
| Equity | 254,681,431.00 | 247,215,363.00 | 295,921,207.00 | 279,989,405.00 | 255,574,007.00 |
| Issued Capital | N/A | 24,492,825.00 | 24,492,825.00 | 24,492,825.00 | 24,492,825.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | N/A | 57,414,177.00 | 47,948,844.00 | 46,103,360.00 |
| Statutory Reserve | N/A | 2,449,283.00 | 2,449,283.00 | 2,449,283.00 | 2,449,283.00 |
| Equity Attributable To Owners Of Parent | N/A | 241,466,671.00 | 289,258,776.00 | 273,585,222.00 | 247,910,361.00 |
| Noncontrolling Interests | N/A | 5,748,692.00 | 6,662,431.00 | 6,404,183.00 | 7,663,646.00 |
| Noncurrent Liabilities | N/A | 37,315,542.00 | 121,028,937.00 | 48,934,069.00 | 38,516,999.00 |
| Deferred Tax Liabilities | N/A | 1,806,032.00 | 5,579,195.00 | 4,856,278.00 | 3,626,925.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 35,114,910.00 | 36,912,326.00 | 34,304,488.00 | 34,533,436.00 |
| Longterm Borrowings | N/A | 0.00 | 78,136,408.00 | 9,375,586.00 | 0.00 |
| Current Liabilities | N/A | 51,624,888.00 | 69,873,777.00 | 89,631,281.00 | 69,286,728.00 |
| Current Provisions | N/A | 72,545.00 | 0.00 | N/A | N/A |
| Trade And Other Current Payables To Trade Suppliers | N/A | 4,418,226.00 | 4,003,740.00 | 4,333,217.00 | 7,345,213.00 |
| Other Current Payables | N/A | 37,061,693.00 | 40,983,915.00 | 54,819,105.00 | 59,716,921.00 |
| Current Tax Liabilities Current | N/A | 10,048,388.00 | 16,005,952.00 | 11,928,558.00 | 2,197,336.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 0.00 | 8,853,829.00 | 18,522,296.00 | 0.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
01.01.2023/ 01.01.2024 |
|---|---|---|---|---|
| Revenue | 126,520,057.00 | 168,186,805.00 | 201,959,951.00 | 178,523,977.00 |
| Other Income | 5,264,861.00 | 1,305,827.00 | 3,767,343.00 | 1,545,489.00 |
| Changes In Inventories Of Finished Goods And Work In Progress | 4,324,601.00 | -3,452,902.00 | 772,075.00 | 704,274.00 |
| Other Work Performed By Entity And Capitalised | 1,239,801.00 | 1,105,836.00 | 587,915.00 | N/A |
| Raw Materials And Consumables Used | 12,013,109.00 | 11,421,404.00 | 18,662,703.00 | 23,405,777.00 |
| Employee Benefits Expense | 50,861,528.00 | 60,755,553.00 | 73,154,782.00 | 65,035,465.00 |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 12,412,405.00 | 10,948,422.00 | 37,867,992.00 | 10,799,732.00 |
| Other Expense By Nature | 7,607,690.00 | 4,648,823.00 | 4,845,092.00 | 1,028,843.00 |
| Profit Loss From Operating Activities | 34,429,808.00 | 73,238,541.00 | 55,744,902.00 | 61,985,157.00 |
| Finance Income | 4,860,689.00 | 8,059,609.00 | 26,794,435.00 | 12,105,421.00 |
| Finance Costs | 6,912,388.00 | 2,062,103.00 | 8,794,505.00 | 7,542,460.00 |
| Profit Loss Before Tax | 31,983,809.00 | 77,695,812.00 | 73,825,731.00 | 65,524,414.00 |
| Profit (loss) | 19,061,218.00 | 63,536,684.00 | 55,280,329.00 | 51,718,761.00 |
| Profit Loss Attributable To Owners Of Parent | 16,437,566.00 | 57,414,177.00 | 47,948,844.00 | 46,103,360.00 |
| Profit Loss Attributable To Noncontrolling Interests | 2,623,655.00 | 6,122,507.00 | 7,331,485.00 | 5,615,401.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 | 01.01.2024 |
|---|---|---|---|---|---|
| Profit (loss) | N/A | 19,061,218.00 | 63,536,684.00 | 55,280,329.00 | 51,718,761.00 |
| Adjustments For Income Tax Expense | N/A | 14,687,702.00 | 21,306,905.00 | 29,389,545.00 | 19,696,109.00 |
| Adjustments For Decrease Increase In Inventories | N/A | 151,135.00 | -6,112,598.00 | 1,391,037.00 | 765,945.00 |
| Adjustments For Fair Value Gains Losses | N/A | 4,806,752.00 | 1,380,915.00 | -2,378,830.00 | -1,213,115.00 |
| Adjustments For Undistributed Profits Of Associates | N/A | 1,765,112.00 | 7,147,177.00 | 10,844,143.00 | 5,890,456.00 |
| Other Adjustments For Noncash Items | N/A | 2,941,766.00 | -1,526,193.00 | -9,102,961.00 | 1,281,260.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | 394,299.00 | 1,540,235.00 | 344,053.00 | 1,023,704.00 |
| Dividends Received Classified As Operating Activities | N/A | 3,302,248.00 | 3,383,509.00 | 7,126,982.00 | 8,292,174.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 14,340,158.00 | 21,664,691.00 | 28,346,768.00 | 27,880,824.00 |
| Cash Flows From Used In Operating Activities | N/A | 35,861,238.00 | 69,168,298.00 | 91,326,100.00 | 62,757,954.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 1,074,313.00 | 977,739.00 | 2,534,443.00 | 661,527.00 |
| Interest Received Classified As Investing Activities | N/A | N/A | 3,521,702.00 | 5,700,645.00 | 8,885,904.00 |
| Cash Flows From Used In Investing Activities | N/A | -11,064,689.00 | -5,994,413.00 | 60,882,172.00 | 58,897,374.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 0.00 | 12,082,392.00 | 0.00 | 3,130.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | -1,974.00 | 483,046.00 | 65,642,097.00 | 27,484,691.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 504,552.00 | 25,145.00 | 28,470.00 | 27,689.00 |
| Interest Paid Classified As Financing Activities | N/A | N/A | N/A | 0.00 | 1,065,108.00 |
| Cash Flows From Used In Financing Activities | N/A | -16,646,401.00 | -11,558,387.00 | -131,974,809.00 | -101,266,071.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -910,690.00 | 1,957,095.00 | 1,009,875.00 | -462,646.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 7,239,458.00 | 53,572,593.00 | 21,243,338.00 | 19,926,611.00 |
| Cash and cash equivalents | 12,592,654.00 | 19,832,116.00 | 73,404,709.00 | 94,648,047.00 | 114,574,658.00 |
Please note that some sums might not add up.
LU0092047413
222100I5M4DM5G5NES09
Lux General Index
LuxX Index
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.